Zobrazeno 1 - 10
of 599
pro vyhledávání: '"M A Olson"'
Autor:
Nasibeh Zanjirani Farahani, PhD, Mateo Alzate Aguirre, MD, Vanessa Karlinski Vizentin, MD, Moein Enayati, PhD, J. Martijn Bos, MD, PhD, Andredi Pumarejo Medina, MD, Kathryn F. Larson, MD, Kalyan S. Pasupathy, PhD, Christopher G. Scott, MS, April L. Zacher, MS, Eduard Schlechtinger, MS, Bruce K. Daniels, RDCS, Vinod C. Kaggal, MS, Jeffrey B. Geske, MD, Patricia A. Pellikka, MD, Jae K. Oh, MD, Steve R. Ommen, MD, Garvan C. Kane, MD, Michael J. Ackerman, MD, PhD, Adelaide M. Arruda-Olson, MD, PhD
Publikováno v:
Mayo Clinic Proceedings: Digital Health, Vol 2, Iss 4, Pp 564-573 (2024)
Objective: To develop machine learning tools for automated hypertrophic cardiomyopathy (HCM) case recognition from echocardiographic metrics, aiming to identify HCM from standard echocardiographic data with high performance. Patients and Methods: Fou
Externí odkaz:
https://doaj.org/article/6ddece60adbe4ec0872121c1ca8a7c1c
Autor:
Elise M. B. Olson, Jasmin G. John, John P. Dunne, Charles Stock, Elizabeth J. Drenkard, Adrienne J. Sutton
Publikováno v:
Earth and Space Science, Vol 11, Iss 7, Pp n/a-n/a (2024)
Abstract Global Earth system models are often enlisted to assess the impacts of climate variability and change on marine ecosystems. In this study, we compare high frequency (daily) outputs of potential ecosystem stressors, such as sea surface temper
Externí odkaz:
https://doaj.org/article/c46934ba18d7475c82570dfc47f30c28
Publikováno v:
Biomedicines, Vol 12, Iss 9, p 2068 (2024)
Polychlorinated biphenyls (PCBs) are a group of 209 highly stable molecules that were used extensively in industry. Although their commercial use ceased in 1979, they are still present in many aquatic ecosystems due to improper disposal, oceanic curr
Externí odkaz:
https://doaj.org/article/4558a12aa20640d9a1bfc38d125707ec
Autor:
Robert D. McBane, Dennis H. Murphree, David Liedl, Francisco Lopez‐Jimenez, Itzhak Zachi Attia, Adelaide M. Arruda‐Olson, Christopher G. Scott, Naresh Prodduturi, Steve E. Nowakowski, Thom W. Rooke, Ana I. Casanegra, Waldemar E. Wysokinski, Damon E. Houghton, Haraldur Bjarnason, Paul W. Wennberg
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 3 (2024)
Background Patients with peripheral artery disease are at increased risk for major adverse cardiac events, major adverse limb events, and all‐cause death. Developing tools capable of identifying those patients with peripheral artery disease at grea
Externí odkaz:
https://doaj.org/article/f37b3dfd89a24f6487ed35029cdafda9
Autor:
Vidhu Anand, Megan K. Covington, Ushasi Saraswati, Christopher G. Scott, Alexander T. Lee, Robert P. Frantz, Nandan S. Anavekar, Jeffrey B. Geske, Adelaide M. Arruda-Olson, Kyle W. Klarich
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2024)
IntroductionApical hypertrophic cardiomyopathy (ApHCM) is a subtype of hypertrophic cardiomyopathy (HCM) that affects up to 25% of Asian patients and is not as well understood in non-Asian patients. Although ApHCM has been considered a more “benign
Externí odkaz:
https://doaj.org/article/e16aff4668c5466b877c1e68faaf9cff
Autor:
Maren Maanja, MD, PhD, Peter A. Noseworthy, MD, FHRS, Jeffrey B. Geske, MD, Michael J. Ackerman, MD, PhD, Adelaide M. Arruda-Olson, MD, PhD, Steve R. Ommen, MD, Zachi I. Attia, PhD, Paul A. Friedman, MD, FHRS, Konstantinos C. Siontis, MD, FHRS
Publikováno v:
Cardiovascular Digital Health Journal, Vol 3, Iss 6, Pp 289-296 (2022)
Background: An electrocardiogram (ECG)-based artificial intelligence (AI) algorithm has shown good performance in detecting hypertrophic cardiomyopathy (HCM). However, its application in routine clinical practice may be challenging owing to the low d
Externí odkaz:
https://doaj.org/article/d6a32c2b206d4643bfa0e0bbcbb3a8d4
Autor:
Nakeya Dewaswala, David Chen, Huzefa Bhopalwala, Vinod C. Kaggal, Sean P. Murphy, J. Martijn Bos, Jeffrey B. Geske, Bernard J. Gersh, Steve R. Ommen, Philip A. Araoz, Michael J. Ackerman, Adelaide M. Arruda-Olson
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Cardiac magnetic resonance (CMR) imaging is important for diagnosis and risk stratification of hypertrophic cardiomyopathy (HCM) patients. However, collection of information from large numbers of CMR reports by manual review is ti
Externí odkaz:
https://doaj.org/article/d9a6ce6d492547be984e9f1a91551f18
Autor:
Simon Gaviria-Valencia, Sean P Murphy, Vinod C Kaggal, Robert D McBane II, Thom W Rooke, Rajeev Chaudhry, Mateo Alzate-Aguirre, Adelaide M Arruda-Olson
Publikováno v:
JMIR Medical Informatics, Vol 11, p e40964 (2023)
BackgroundManagement of abdominal aortic aneurysms (AAAs) requires serial imaging surveillance to evaluate the aneurysm dimension. Natural language processing (NLP) has been previously developed to retrospectively identify patients with AAA from elec
Externí odkaz:
https://doaj.org/article/0b07e2770cde4945b22e21b0472cc5d8
Autor:
Konstantinos C. Siontis, MD, Huzefa Bhopalwala, MD, Nakeya Dewaswala, MD, Christopher G. Scott, MS, Peter A. Noseworthy, MD, FHRS, Jeffrey B. Geske, MD, Steve R. Ommen, MD, Rick A. Nishimura, MD, Michael J. Ackerman, MD, PhD, Paul A. Friedman, MD, FHRS, Adelaide M. Arruda-Olson, MD, PhD
Publikováno v:
Cardiovascular Digital Health Journal, Vol 2, Iss 5, Pp 264-269 (2021)
Background: The follow-up of implantable cardioverter-defibrillators (ICDs) generates large amounts of valuable structured and unstructured data embedded in device interrogation reports. Objective: We aimed to build a natural language processing (NLP
Externí odkaz:
https://doaj.org/article/3f330040537243c097b35b31433cd3dd
Autor:
Michelle Partogi, Simon Gaviria-Valencia, Mateo Alzate Aguirre, Nancy J Pick, Huzefa M Bhopalwala, Barbara A Barry, Vinod C Kaggal, Christopher G Scott, Maya E Kessler, Matthew M Moore, Jay D Mitchell, Rajeev Chaudhry, Robert P Bonacci, Adelaide M Arruda-Olson
Publikováno v:
Journal of Medical Internet Research, Vol 24, Iss 8, p e27333 (2022)
BackgroundClinical practice guidelines recommend antiplatelet and statin therapies as well as blood pressure control and tobacco cessation for secondary prevention in patients with established atherosclerotic cardiovascular diseases (ASCVDs). However
Externí odkaz:
https://doaj.org/article/5a1ff330f84841af9bf2adc4c75454ae